| Title |
Dendritic Cell Based Tumor Vaccination in Prostate and Renal Cell Cancer: A Systematic Review and Meta-Analysis
|
|---|---|
| Published in |
PLOS ONE, April 2011
|
| DOI | 10.1371/journal.pone.0018801 |
| Pubmed ID | |
| Authors |
Andreas Draube, Nela Klein-González, Stefanie Mattheus, Corinne Brillant, Martin Hellmich, Andreas Engert, Michael von Bergwelt-Baildon |
| Abstract |
More than 200 clinical trials have been performed using dendritic cells (DC) as cellular adjuvants in cancer. Yet the key question whether there is a link between immune and clinical response remains unanswered. Prostate and renal cell cancer (RCC) have been extensively studied for DC-based immunotherapeutic interventions and were therefore chosen to address the above question by means of a systematic review and meta-analysis. |
Mendeley readers
The data shown below were compiled from readership statistics for 169 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Austria | 1 | <1% |
| Unknown | 168 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 38 | 22% |
| Student > Master | 26 | 15% |
| Student > Ph. D. Student | 21 | 12% |
| Student > Bachelor | 15 | 9% |
| Student > Doctoral Student | 10 | 6% |
| Other | 33 | 20% |
| Unknown | 26 | 15% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 50 | 30% |
| Agricultural and Biological Sciences | 42 | 25% |
| Immunology and Microbiology | 24 | 14% |
| Biochemistry, Genetics and Molecular Biology | 8 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 3% |
| Other | 10 | 6% |
| Unknown | 30 | 18% |